首页 > 最新文献

Aging Medicine最新文献

英文 中文
Pulse field ablation for atrial fibrillation: Is the curtain about to rise? 脉冲场消融治疗心房颤动:大幕即将拉开?
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-18 DOI: 10.1002/agm2.12326
Junpeng Liu, Min Dong, Jiefu Yang
<p>Catheter ablation has been validated as an effective intervention for atrial fibrillation (AF) patients, significantly reducing recurrence rates, improving prognoses, and enhancing life quality.<span><sup>1-3</sup></span> However, conventional methods employing radiofrequency or cryothermal energy suffer from a lack of tissue specificity, potentially leading to complications such as pulmonary vein stenosis, atrioesophageal fistula, and hemidiaphragmatic paralysis.<span><sup>2, 3</sup></span> Pulsed field ablation (PFA) has recently emerged as a promising alternative, utilizing the microsecond-scale, high-voltage electrical fields to induce irreversible electroporation and cell membrane destabilization, culminating in cellular necrosis.<span><sup>4, 5</sup></span> Its superior tissue selectivity minimizes damage to non-target tissues during ablation, positioning PFA as an ideal modality for cardiac ablation.</p><p>Preclinical experiments utilizing animal models have underscored the potential of PFA for achieving durable pulmonary vein isolation (PVI),<span><sup>6, 7</sup></span> highlighting the method's capability to form comprehensive transmural lesions devoid of adverse effects like pulmonary vein ostia stenosis or esophageal damage.<span><sup>8, 9</sup></span> Notably, PFA's application has shown efficacy in permanently neutralizing the atrial ganglion plexus without compromising atrial myocardium integrity or triggering inflammatory responses and fibrosis.<span><sup>7-9</sup></span></p><p>In 2018, Reddy and colleagues<span><sup>10</sup></span> pioneered the application of PFA for the clinical management of paroxysmal AF Their groundbreaking work revealed that an average of 3.26 ablations was sufficient to achieve complete PVI with an operation duration of approximately 67 ± 10.5 min. The procedure was characterized by minimal chest and diaphragmatic sensations, yet remarkably, it resulted in no complications. Follow-up studies involving 81 patients undergoing mono-phase and bi-phase PFA demonstrated 100% acute isolation of pulmonary veins, with the procedure taking an average of 92.2 ± 27.4 min and the ablation itself 13.1 ± 7.6 min.<span><sup>11</sup></span> Given the pivotal role of pulmonary vein reconnection in ablation recurrence, the stability of PVI post-procedure emerges as crucial. Notably, advancements in PFA waveform technology have significantly increased PVI durability from 18% to a full 100% at the 3-month benchmark. Aside from a single incident of cardiac tamponade related to the operation, no severe complications were reported within the first 120 days post-ablation. At the one-year follow-up mark, the rate of sinus rhythm maintenance impressively stood at 87.4%. These findings collectively affirm the efficacy of PFA in achieving swift and durable PVI, primarily through selective myocardial tissue targeting, while maintaining a commendable safety profile.</p><p>Nevertheless, the inherent challenge of high recurrence rates i
参与者被平均分配到 PFA 组(n = 305)或热消融组(n = 302),其中包括 167 名接受射频消融术的患者和 135 名接受冷冻气球消融术的患者。两组患者的基线特征完全匹配。在研究空白期,允许使用 I 类和 III 类抗心律失常药物,但不包括胺碘酮。通过电话和门诊访问进行了细致的随访,并在 6 个月和 12 个月时使用 72 小时 Holter 监护仪进行心律评估,每周还对症状进行远程监测。值得注意的是,两组患者实现 PVI 的即时成功率都很高,PFA 组为 99.6%,热消融组为 99.8%,这突显了 PFA 的疗效。值得注意的是,PFA 减少了手术时间、左心房停留时间和消融时间,但需要更长的 X 光透视时间。一年后,PFA 的有效率为 73.3%,与热消融队列中 71.3% 的有效率非常接近,符合两种方法非劣效性的标准。安全性分析表明,各组间主要不良事件的情况相当,进一步验证了 PFA 在安全性方面的非劣效性。此外,该研究还证明了 PFA 在保留肺静脉横截面积方面的优越性,表明与热消融技术相比,PFA 的狭窄风险更低。从本质上讲,ADVENT 研究是临床研究领域的一个里程碑,它是首个随机对照试验 (RCT),验证了在治疗阵发性房颤时,与既有的热消融方法相比,PFA 无劣效性。PULSE 房颤关键试验是一项前瞻性、全球性、多中心、非随机对照、单臂研究,旨在评估 PulseSelect 脉冲场消融系统(美敦力)治疗阵发性和持续性房颤的有效性和安全性。2023 年 3 月,《循环》(Circulation)杂志详细报道了这项横跨 9 个国家、41 个中心的大型研究,在长达一年的观察期内,共有 300 名患者参与了研究,其中阵发性房颤和持续性房颤病例各占一半。这项研究以严格定义的终点为特色,主要针对急性手术成功、无心律失常复发或需要增加抗心律失常药物治疗的综合指标。经过一年的精心随访,试验结果表明,66.2% 的阵发性房颤患者和 55.1% 的持续性房颤患者达到了主要疗效终点。值得注意的是,阵发性房颤组和持续性房颤组的无症状房性心律失常复发率分别达到了 79.7% 和 80.8%。重大不良事件的总体发生率非常低,仅为 0.7%,未报告食管损伤、肺静脉狭窄或膈神经损伤的发生率--这使该试验的安全性成为迄今为止 PFA 研究中最理想的结果之一。在对 287 名参与者进行的 12 个月随访中,96% 的完成率令人印象深刻,这提供了可靠的长期数据。这些令人信服的结果在确保 PulseSelect PFA 系统获得监管部门批准方面发挥了至关重要的作用,标志着该系统于 2023 年 12 月 14 日成为同类产品中首个获得美国食品药品管理局(FDA)批准用于治疗阵发性和持续性房颤的产品,具有重要的里程碑意义。在 Urbanek 及其同事进行的一项综合性队列比较研究中,400 名患者(56.5% 为男性,60.8% 为阵发性房颤患者,平均年龄 70 岁)被平均分为两组,分别接受冷冻消融或 PFA 治疗16。冷冻消融组使用美敦力公司的 28 毫米第二代冷冻球囊(Arctic Front Advance)进行治疗,而 PFA 组则使用波士顿科学公司的 31 毫米或 35 毫米 Farawave 脉冲消融导管进行治疗。值得注意的是,研究显示 PFA 患者的即时 PVI 成功率为 100%,而冷冻消融患者的成功率为 98%。值得注意的是,PFA 手术的中位手术时间为 34.5 分钟,明显短于冷冻消融术的 50 分钟,两者的透视时间相当。PFA组的总体并发症发生率较低,为3.0%,而冷冻消融组为6.5%,这主要是因为冷冻消融导致膈神经麻痹的发生率较高。 经过一年的随访,两种方法的成功率(以无房性心律失常复发为标准)非常接近:在阵发性房颤患者中,冷冻消融术的成功率为 83.1%,而 PFA 为 80.3%;在持续性房颤患者中,冷冻消融术的成功率为 71%,而 PFA 为 66.8%,这表明两种方法的疗效没有显著差异。这项研究证实,在治疗效果方面,PFA 不劣于冷冻消融术,而 PFA 在降低膈神经麻痹风险方面具有特别的安全优势。继这项研究之后,波士顿科学公司的 PFA 产品 FARAPULSE 于 2024 年 1 月获得 FDA 批准,成为首个获得此类认证的 PFA 系统,并在 2021 年 1 月获得 CE 认证。2023 年 12 月 27 日,中国国家医疗器械监督管理局(NMPA)批准了四川锦江电子的创新产品 LEAD-PFA 心脏 PFA 仪器和 PulsedFA PFA 导管的市场准入,这是心脏消融治疗领域的一个重要里程碑17 。这一批准是更广泛趋势的一部分,因为目前国内正在积极开发多种 PFA 产品,包括北核医疗的 LotosPFA 消融导管、Deno Electrophysiology 的 CardioPulsePFA 消融导管、宣宇医疗的 PFA 系统和迈为医疗的 nsPFA 系统。国家医疗器械管理局(NMPA)和美国食品和药物管理局(FDA)同时向各种 PFA 产品颁发了医疗器械注册证书,这表明全球已进入通过 PFA 治疗心律失常的新时代。尽管取得了这些进步,但必须承认,PFA 技术仍处于新生阶段,这一领域还有广阔的天地有待探索和了解。PFA 的基本原理在于电穿孔,这是一种利用电场精确定位和破坏组织结构的非热效应方法。这些改变损害了细胞的完整性和活力,这是 PFA 有效的核心机制。这种技术被称为不可逆电穿孔,与特定的 PFA 参数和所用电极的配置密切相关。18 尽管 PFA 潜力巨大,但由于现有专利问题,其开发和标准化面临挑战。18 尽管 PFA 潜力巨大,但由于现有的专利问题,其开发和标准化面临挑战。这阻碍了 PFA 应用公认标准的建立,导致其在临床应用中存在相当大的差异。这种差异导致不同的 PFA 应用在临床结果和安全性方面存在差异。因此,虽然 PFA 代表了治疗领域的一大进步,但其广泛认可和应用却受到了限制,这就需要进行严格、有针对性的研究,以验证其在不同临床情况下的有效性和安全性。PFA 的一个显著潜在优势在于缩短了实现肺静脉电隔离所需的时间。不过,由于 PFA 手术需要全身麻醉,因此手术的总体持续时间可能不会明显缩短,而且有可能比传统方法更长。不过,随着 PFA 技术的不断进步和麻醉技术的简化,预计手术时间将会缩短。在安全性方面,临床前研究强调 PFA 有可能将肺静脉狭窄、寰咽瘘和半膈麻痹的风险降至最低。造成这一差距的原因是现有研究的规模有限,因此需要进行更广泛的研究。 此外,传统消融技术在减少并发症方面的公认疗效也使直接比较变得更加复杂。此外,人们还担心 PFA 会增加心包填塞和中风的发生率,这可能与 PFA 设备的操作熟练程度和从业人员的经验水平有关。预计随着 PFA 技术和手术技巧的不断进步,以及操作人员专业知识的不断提高,将有助于减少这些并发症的发生。此外,必须关注 PFA 引起的冠状动脉损伤,主要分为直接损伤和冠状动脉痉挛。19 值得注意的是,PFA 引起冠状动脉痉挛的事例已有记载,Reddy 等人观察到,在远离冠状动脉的手术中不会引起冠状动脉痉挛,但在靠近这些血管的
{"title":"Pulse field ablation for atrial fibrillation: Is the curtain about to rise?","authors":"Junpeng Liu,&nbsp;Min Dong,&nbsp;Jiefu Yang","doi":"10.1002/agm2.12326","DOIUrl":"https://doi.org/10.1002/agm2.12326","url":null,"abstract":"&lt;p&gt;Catheter ablation has been validated as an effective intervention for atrial fibrillation (AF) patients, significantly reducing recurrence rates, improving prognoses, and enhancing life quality.&lt;span&gt;&lt;sup&gt;1-3&lt;/sup&gt;&lt;/span&gt; However, conventional methods employing radiofrequency or cryothermal energy suffer from a lack of tissue specificity, potentially leading to complications such as pulmonary vein stenosis, atrioesophageal fistula, and hemidiaphragmatic paralysis.&lt;span&gt;&lt;sup&gt;2, 3&lt;/sup&gt;&lt;/span&gt; Pulsed field ablation (PFA) has recently emerged as a promising alternative, utilizing the microsecond-scale, high-voltage electrical fields to induce irreversible electroporation and cell membrane destabilization, culminating in cellular necrosis.&lt;span&gt;&lt;sup&gt;4, 5&lt;/sup&gt;&lt;/span&gt; Its superior tissue selectivity minimizes damage to non-target tissues during ablation, positioning PFA as an ideal modality for cardiac ablation.&lt;/p&gt;&lt;p&gt;Preclinical experiments utilizing animal models have underscored the potential of PFA for achieving durable pulmonary vein isolation (PVI),&lt;span&gt;&lt;sup&gt;6, 7&lt;/sup&gt;&lt;/span&gt; highlighting the method's capability to form comprehensive transmural lesions devoid of adverse effects like pulmonary vein ostia stenosis or esophageal damage.&lt;span&gt;&lt;sup&gt;8, 9&lt;/sup&gt;&lt;/span&gt; Notably, PFA's application has shown efficacy in permanently neutralizing the atrial ganglion plexus without compromising atrial myocardium integrity or triggering inflammatory responses and fibrosis.&lt;span&gt;&lt;sup&gt;7-9&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;In 2018, Reddy and colleagues&lt;span&gt;&lt;sup&gt;10&lt;/sup&gt;&lt;/span&gt; pioneered the application of PFA for the clinical management of paroxysmal AF Their groundbreaking work revealed that an average of 3.26 ablations was sufficient to achieve complete PVI with an operation duration of approximately 67 ± 10.5 min. The procedure was characterized by minimal chest and diaphragmatic sensations, yet remarkably, it resulted in no complications. Follow-up studies involving 81 patients undergoing mono-phase and bi-phase PFA demonstrated 100% acute isolation of pulmonary veins, with the procedure taking an average of 92.2 ± 27.4 min and the ablation itself 13.1 ± 7.6 min.&lt;span&gt;&lt;sup&gt;11&lt;/sup&gt;&lt;/span&gt; Given the pivotal role of pulmonary vein reconnection in ablation recurrence, the stability of PVI post-procedure emerges as crucial. Notably, advancements in PFA waveform technology have significantly increased PVI durability from 18% to a full 100% at the 3-month benchmark. Aside from a single incident of cardiac tamponade related to the operation, no severe complications were reported within the first 120 days post-ablation. At the one-year follow-up mark, the rate of sinus rhythm maintenance impressively stood at 87.4%. These findings collectively affirm the efficacy of PFA in achieving swift and durable PVI, primarily through selective myocardial tissue targeting, while maintaining a commendable safety profile.&lt;/p&gt;&lt;p&gt;Nevertheless, the inherent challenge of high recurrence rates i","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"287-291"},"PeriodicalIF":2.2,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12326","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141536912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A hypothesis: MiRNA-124 mediated regulation of sirtuin 1 and vitamin D receptor gene expression accelerates aging 一个假设MiRNA-124 介导的 sirtuin 1 和维生素 D 受体基因表达调控会加速衰老
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-15 DOI: 10.1002/agm2.12330
Poulami Dhar, Shailaja Moodithaya, Prakash Patil, Kellarai Adithi

Objectives

Specific miRNAs are evident to be overexpressed with age, lifestyle, and environmental changes. Previous studies reported miR-124 overexpression in different scenarios in aged skin, age-related cognitive impairment, ischemic heart disease, muscle atrophy, and fractures. Thus miR-124 was considered to be a reliable miRNA target to establish a hypothesis on aging epigenome. Parallelly the hypothesis focuses on the expression of SIRT1 and VDR genes as a target for this specific miRNA expression as these genes were believed to be related to aging. This study aims to derive facts and evidence from past studies on aging. The objective was to establish a hypothetical linkage between miR-124 with age-related genes like SIRT1 and VDR.

Methods

An in silico search was performed in the TargetScan and miRbase databases to analyze the aging-associated miRNAs and their gene targets, the Python seaborn library was used, and the results were represented in terms of a bar plot.

Results

Based on an in silico analysis and studies available in the literature, we identified that miR-124-3p.1 and miR-124-3p.2 targets 3′ UTR of VDR and SIRT1 genes, and hence thereby indicates that the miR-124 can regulate the expression of these genes. Further, few in vitro research studies have observed that miR-124 overexpression leads to the downregulation of VDR and SIRT1 gene expression. These results indicate that the suppression of these target genes accelerates early aging and age-related disorders.

Conclusions

Overall, this study hypothesizes that the overexpression of miR-124 diminishes the expression of VDR and SIRT1 genes, and thereby advances the process of aging, resulting in the development of age-associated complications.

随着年龄的增长、生活方式和环境的变化,特定的 miRNA 显然会过度表达。先前的研究报告了 miR-124 在老化皮肤、老年性认知障碍、缺血性心脏病、肌肉萎缩和骨折等不同情况下的过表达。因此,miR-124 被认为是建立衰老表观基因组假说的可靠 miRNA 靶点。同时,该假说还把 SIRT1 和 VDR 基因的表达作为这一特定 miRNA 表达的靶点,因为这些基因被认为与衰老有关。本研究旨在从过去有关衰老的研究中得出事实和证据。我们在 TargetScan 和 miRbase 数据库中进行了硅学搜索,以分析与衰老相关的 miRNA 及其基因靶标,并使用 Python seaborn 文库,以柱状图的形式表示结果。和 miR-124-3p.2 以 VDR 和 SIRT1 基因的 3′ UTR 为靶标,从而表明 miR-124 可调控这些基因的表达。此外,少数体外研究观察到,miR-124 过表达会导致 VDR 和 SIRT1 基因表达下调。总之,本研究推测,miR-124 的过度表达会降低 VDR 和 SIRT1 基因的表达,从而推进衰老进程,导致老年相关并发症的发生。
{"title":"A hypothesis: MiRNA-124 mediated regulation of sirtuin 1 and vitamin D receptor gene expression accelerates aging","authors":"Poulami Dhar,&nbsp;Shailaja Moodithaya,&nbsp;Prakash Patil,&nbsp;Kellarai Adithi","doi":"10.1002/agm2.12330","DOIUrl":"10.1002/agm2.12330","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Specific miRNAs are evident to be overexpressed with age, lifestyle, and environmental changes. Previous studies reported miR-124 overexpression in different scenarios in aged skin, age-related cognitive impairment, ischemic heart disease, muscle atrophy, and fractures. Thus miR-124 was considered to be a reliable miRNA target to establish a hypothesis on aging epigenome. Parallelly the hypothesis focuses on the expression of SIRT1 and VDR genes as a target for this specific miRNA expression as these genes were believed to be related to aging. This study aims to derive facts and evidence from past studies on aging. The objective was to establish a hypothetical linkage between miR-124 with age-related genes like SIRT1 and VDR.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An in silico search was performed in the TargetScan and miRbase databases to analyze the aging-associated miRNAs and their gene targets, the Python seaborn library was used, and the results were represented in terms of a bar plot.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Based on an in silico analysis and studies available in the literature, we identified that miR-124-3p.1 and miR-124-3p.2 targets 3′ UTR of VDR and SIRT1 genes, and hence thereby indicates that the miR-124 can regulate the expression of these genes. Further, few in vitro research studies have observed that miR-124 overexpression leads to the downregulation of VDR and SIRT1 gene expression. These results indicate that the suppression of these target genes accelerates early aging and age-related disorders.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Overall, this study hypothesizes that the overexpression of miR-124 diminishes the expression of VDR and SIRT1 genes, and thereby advances the process of aging, resulting in the development of age-associated complications.</p>\u0000 </section>\u0000 </div>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"320-327"},"PeriodicalIF":2.2,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12330","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141336458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guideline for the cognitive assessment and follow-up in the Guangdong-Hong Kong-Macao Greater Bay Area (2024 edition) 粤港澳大湾区认知能力评估及跟进指南(2024年版)
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-15 DOI: 10.1002/agm2.12325
Jialing Peng, Yingreng Mai, Jun Liu

This practice guideline focuses on the cognitive assessment for mild cognitive impairment in the Guangdong-Hong Kong-Macao Greater Bay Area. To achieve the standardization and normalization of its clinical practice and generate individualized intervention, the National Core Cognitive Center of the Second Affiliated Hospital of Guangzhou Medical University, the Cognitive Disorders Branch of Chinese Geriatic Society, the Dementia Group of Neurology Branch of Guangdong Medical Association and specialists from Hong Kong and Macao developed guidelines based on China's actual conditions and efficiency, economic cost and accuracy. The article addresses the significance, background, and the process of the assessment and follow-up to realize the promotion and dissemination of cognitive assessment.

本实践指南主要针对粤港澳大湾区轻度认知障碍的认知评估。为实现其临床实践的标准化和规范化,并产生个体化干预,广州医科大学附属第二医院国家认知核心中心、中国老年学学会认知障碍分会、广东省医学会神经病学分会痴呆学组及港澳专家根据我国实际情况,以高效、经济、准确为原则,制定了该指南。文章阐述了认知评估的意义、背景、评估和随访过程,以实现认知评估的推广和普及。
{"title":"Guideline for the cognitive assessment and follow-up in the Guangdong-Hong Kong-Macao Greater Bay Area (2024 edition)","authors":"Jialing Peng,&nbsp;Yingreng Mai,&nbsp;Jun Liu","doi":"10.1002/agm2.12325","DOIUrl":"10.1002/agm2.12325","url":null,"abstract":"<p>This practice guideline focuses on the cognitive assessment for mild cognitive impairment in the Guangdong-Hong Kong-Macao Greater Bay Area. To achieve the standardization and normalization of its clinical practice and generate individualized intervention, the National Core Cognitive Center of the Second Affiliated Hospital of Guangzhou Medical University, the Cognitive Disorders Branch of Chinese Geriatic Society, the Dementia Group of Neurology Branch of Guangdong Medical Association and specialists from Hong Kong and Macao developed guidelines based on China's actual conditions and efficiency, economic cost and accuracy. The article addresses the significance, background, and the process of the assessment and follow-up to realize the promotion and dissemination of cognitive assessment.</p>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"258-268"},"PeriodicalIF":2.2,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12325","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141336801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical biomarker-based biological aging and risk of benign prostatic hyperplasia: A large prospective cohort study 基于临床生物标志物的生物衰老与良性前列腺增生的风险:一项大型前瞻性队列研究
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-14 DOI: 10.1002/agm2.12331
Qiao Huang, Bing-Hui Li, Yong-Bo Wang, Hao Zi, Yuan-Yuan Zhang, Fei Li, Cheng Fang, Shi-Di Tang, Ying-Hui Jin, Jiao Huang, Xian-Tao Zeng

Objective

Chronological age (CAge), biological age (BAge), and accelerated age (AAge) are all important for aging-related diseases. CAge is a known risk factor for benign prostatic hyperplasia (BPH); However, the evidence of association of BAge and AAge with BPH is limited. This study aimed to evaluate the association of CAge, Bage, and AAge with BPH in a large prospective cohort.

Method

A total of 135,933 males without BPH at enrolment were extracted from the UK biobank. We calculated three BAge measures (Klemera–Doubal method, KDM; PhenoAge; homeostatic dysregulation, HD) based on 16 biomarkers. Additionally, we calculated KDM-BAge and PhenoAge-BAge measures based on the Levine method. The KDM-AAge and PhenoAge-AAge were assessed by the difference between CAge and BAge and were standardized (mean = 0 and standard deviation [SD] = 1). Cox proportional hazard models were applied to assess the associations of CAge, Bage, and AAge with incident BPH risk.

Results

During a median follow-up of 13.150 years, 11,811 (8.690%) incident BPH were identified. Advanced CAge and BAge measures were associated with an increased risk of BPH, showing threshold effects at a later age (all P for nonlinearity <0.001). Nonlinear relationships between AAge measures and risk of BPH were also found for KDM-AAge (P = 0.041) and PhenoAge-AAge (P = 0.020). Compared to the balance comparison group (−1 SD < AAge < 1 SD), the accelerated aging group (AAge > 2 SD) had a significantly elevated BPH risk with hazard ratio (HR) of 1.115 (95% CI, 1.000–1.223) for KDM-AAge and 1.180 (95% CI, 1.068–1.303) for PhenoAge-AAge, respectively. For PhenoAge-AAge, subgroup analysis of the accelerated aging group showed an increased HR of 1.904 (95% CI, 1.374–2.639) in males with CAge <50 years and 1.233 (95% CI, 1.088–1.397) in those having testosterone levels <12 nmol/L. Moreover, AAge-associated risk of BPH was independent of and additive to genetic risk.

Conclusions

Biological aging is an independent and modifiable risk factor for BPH. We suggest performing active health interventions to slow biological aging, which will help mitigate the progression of prostate aging and further reduce the burden of BPH.

生理年龄(CAge)、生物年龄(BAge)和加速年龄(AAge)对与衰老有关的疾病都很重要。慢性年龄是良性前列腺增生症(BPH)的一个已知风险因素;然而,BAge 和 AAge 与良性前列腺增生症相关的证据却很有限。本研究旨在评估大型前瞻性队列中 CAge、Bage 和 AAge 与良性前列腺增生症的关系。我们根据 16 个生物标志物计算了三个 BAge 测量值(Klemera-Doubal 法,KDM;PhenoAge;稳态失调,HD)。此外,我们还根据 Levine 方法计算了 KDM-BAge 和 PhenoAge-BAge 指标。KDM-AAge和PhenoAge-AAge通过CAge和BAge之间的差异进行评估,并进行了标准化(平均值=0,标准差[SD]=1)。在中位随访 13.150 年期间,共发现 11,811 例(8.690%)前列腺增生症。高级CAge和BAge测量值与良性前列腺增生症风险的增加有关,在较晚的年龄(非线性P均为2 SD)显示出阈值效应,其良性前列腺增生症风险显著升高,KDM-AAge的危险比(HR)分别为1.115(95% CI,1.000-1.223),PhenoAge-AAge的危险比(HR)分别为1.180(95% CI,1.068-1.303)。就 PhenoAge-AAge 而言,对加速衰老组进行的亚组分析表明,年龄小于 50 岁的男性的 HR 增加了 1.904(95% CI,1.374-2.639),睾酮水平小于 12 nmol/L 的男性的 HR 增加了 1.233(95% CI,1.088-1.397)。此外,与年龄相关的良性前列腺增生症风险独立于遗传风险,并且与遗传风险相加。我们建议采取积极的健康干预措施来延缓生物衰老,这将有助于缓解前列腺衰老的进程,进一步减轻良性前列腺增生症的负担。
{"title":"Clinical biomarker-based biological aging and risk of benign prostatic hyperplasia: A large prospective cohort study","authors":"Qiao Huang,&nbsp;Bing-Hui Li,&nbsp;Yong-Bo Wang,&nbsp;Hao Zi,&nbsp;Yuan-Yuan Zhang,&nbsp;Fei Li,&nbsp;Cheng Fang,&nbsp;Shi-Di Tang,&nbsp;Ying-Hui Jin,&nbsp;Jiao Huang,&nbsp;Xian-Tao Zeng","doi":"10.1002/agm2.12331","DOIUrl":"10.1002/agm2.12331","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Chronological age (CAge), biological age (BAge), and accelerated age (AAge) are all important for aging-related diseases. CAge is a known risk factor for benign prostatic hyperplasia (BPH); However, the evidence of association of BAge and AAge with BPH is limited. This study aimed to evaluate the association of CAge, Bage, and AAge with BPH in a large prospective cohort.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>A total of 135,933 males without BPH at enrolment were extracted from the UK biobank. We calculated three BAge measures (Klemera–Doubal method, KDM; PhenoAge; homeostatic dysregulation, HD) based on 16 biomarkers. Additionally, we calculated KDM-BAge and PhenoAge-BAge measures based on the Levine method. The KDM-AAge and PhenoAge-AAge were assessed by the difference between CAge and BAge and were standardized (mean = 0 and standard deviation [SD] = 1). Cox proportional hazard models were applied to assess the associations of CAge, Bage, and AAge with incident BPH risk.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>During a median follow-up of 13.150 years, 11,811 (8.690%) incident BPH were identified. Advanced CAge and BAge measures were associated with an increased risk of BPH, showing threshold effects at a later age (all <i>P</i> for nonlinearity &lt;0.001). Nonlinear relationships between AAge measures and risk of BPH were also found for KDM-AAge (<i>P</i> = 0.041) and PhenoAge-AAge (<i>P</i> = 0.020). Compared to the balance comparison group (−1 SD &lt; AAge &lt; 1 SD), the accelerated aging group (AAge &gt; 2 SD) had a significantly elevated BPH risk with hazard ratio (HR) of 1.115 (95% CI, 1.000–1.223) for KDM-AAge and 1.180 (95% CI, 1.068–1.303) for PhenoAge-AAge, respectively. For PhenoAge-AAge, subgroup analysis of the accelerated aging group showed an increased HR of 1.904 (95% CI, 1.374–2.639) in males with CAge &lt;50 years and 1.233 (95% CI, 1.088–1.397) in those having testosterone levels &lt;12 nmol/L. Moreover, AAge-associated risk of BPH was independent of and additive to genetic risk.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Biological aging is an independent and modifiable risk factor for BPH. We suggest performing active health interventions to slow biological aging, which will help mitigate the progression of prostate aging and further reduce the burden of BPH.</p>\u0000 </section>\u0000 </div>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"393-405"},"PeriodicalIF":2.2,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12331","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141339995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abuse and other factors related to depression in older Ecuadorian adults 厄瓜多尔老年人中与抑郁症有关的虐待和其他因素
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-14 DOI: 10.1002/agm2.12338
Brenda Lorena Pillajo Sánchez, Marcos Serrano-Dueñas, Diego Alexander Mendoza Panta, Juana Albertina Moncayo Vásquez

Objective

To identify abuse and other risk factors associated with depression in older Ecuadorian adults using data from the 2012 Ecuador's Survey of Health, Welfare, and Aging (SABE).

Methods

This cross-sectional study analyzed data from the 2012 SABE survey, which included 5235 adults aged 60 and above. The study evaluated residence, education level, ethnic self-identification, self-perceived health and memory, loneliness, cognitive status, and abuse. Depression was assessed using the Yesavage Depression Scale, short version (YDS-SV). Categorical variables were analyzed with the Chi-square test, differences between groups were calculated with the Kruskal–Wallis test, and multiple linear regression analysis was performed. A p-value of ≤0.05 was considered statistically significant.

Results

The mean age was 71.39 ± 8.59 years and 55.10% of the sample were women. Abuse was absent in 72.1% (3.773) of the population. The Chi-square test indicated significant associations between depression and poor self-reported health (P = 0.000) and indigenous ethnicity (P = 0.000). Multiple linear regression analysis revealed that age (P < 0.001), abuse (p < 0.001), cognitive status (P = 0.002), and living alone (P = 0.034) significantly contributed to mood as assessed by the YDS-SV. No statistically significant association was found for perceived health status or place of residence (urban or rural).

Conclusions

Risk factors associated with depression in older Ecuadorian adults include advanced age, living alone, cognitive decline, poor self-perception of health and cognition, and abuse.

本横断面研究分析了 2012 年厄瓜多尔健康、福利和老龄化调查(SABE)的数据,其中包括 5235 名 60 岁及以上的成年人。研究评估了居住地、教育水平、种族自我认同、自我感觉健康和记忆力、孤独感、认知状况和虐待情况。抑郁情况采用耶萨维抑郁量表简版(YDS-SV)进行评估。分类变量采用卡方检验进行分析,组间差异采用 Kruskal-Wallis 检验进行计算,并进行了多元线性回归分析。平均年龄为 71.39 ± 8.59 岁,55.10% 的样本为女性。72.1%(3.773)的人没有虐待行为。卡方检验表明,抑郁症与自我健康状况差(P = 0.000)和土著民族(P = 0.000)之间存在明显关联。多元线性回归分析显示,年龄(P < 0.001)、虐待(P < 0.001)、认知状况(P = 0.002)和独居(P = 0.034)对 YDS-SV 评估的情绪有明显影响。与厄瓜多尔老年人抑郁相关的风险因素包括高龄、独居、认知能力下降、对健康和认知的自我感觉不佳以及虐待。
{"title":"Abuse and other factors related to depression in older Ecuadorian adults","authors":"Brenda Lorena Pillajo Sánchez,&nbsp;Marcos Serrano-Dueñas,&nbsp;Diego Alexander Mendoza Panta,&nbsp;Juana Albertina Moncayo Vásquez","doi":"10.1002/agm2.12338","DOIUrl":"10.1002/agm2.12338","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To identify abuse and other risk factors associated with depression in older Ecuadorian adults using data from the 2012 Ecuador's Survey of Health, Welfare, and Aging (SABE).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This cross-sectional study analyzed data from the 2012 SABE survey, which included 5235 adults aged 60 and above. The study evaluated residence, education level, ethnic self-identification, self-perceived health and memory, loneliness, cognitive status, and abuse. Depression was assessed using the Yesavage Depression Scale, short version (YDS-SV). Categorical variables were analyzed with the Chi-square test, differences between groups were calculated with the Kruskal–Wallis test, and multiple linear regression analysis was performed. A <i>p</i>-value of ≤0.05 was considered statistically significant.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The mean age was 71.39 ± 8.59 years and 55.10% of the sample were women. Abuse was absent in 72.1% (3.773) of the population. The Chi-square test indicated significant associations between depression and poor self-reported health (<i>P</i> = 0.000) and indigenous ethnicity (<i>P</i> = 0.000). Multiple linear regression analysis revealed that age (<i>P</i> &lt; 0.001), abuse (<i>p</i> &lt; 0.001), cognitive status (<i>P</i> = 0.002), and living alone (<i>P</i> = 0.034) significantly contributed to mood as assessed by the YDS-SV. No statistically significant association was found for perceived health status or place of residence (urban or rural).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Risk factors associated with depression in older Ecuadorian adults include advanced age, living alone, cognitive decline, poor self-perception of health and cognition, and abuse.</p>\u0000 </section>\u0000 </div>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"328-333"},"PeriodicalIF":2.2,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12338","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141341261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Craniectomy versus craniotomy: What can we do for acute subdural hematoma? 颅骨切除术与开颅手术:如何治疗急性硬膜下血肿?
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-14 DOI: 10.1002/agm2.12322
Shuo Zhang, Guoyi Gao, Weiming Liu
<p>Acute subdural hematoma (ASDH) is one of the common complications after traumatic brain injury (TBI) that warrants surgical evacuation. It often progresses rapidly and has a poor clinical prognosis, due to the mass effect caused by the hematoma and the invasion of the adjacent cerebral cortex and parenchyma. Although with the advancement of surgical techniques, the survival rate after ASDH increased from 59% in 1994–1998 to 73% in 2009–2013,<span><sup>1</sup></span> the surgical indications for hematoma evacuation and whether to perform decompression surgery are still controversial which depends on the patient's level of consciousness, pupil status, neuroimaging findings, and intracranial pressure.<span><sup>2</sup></span> Hematoma evacuation is required in a quarter of patients to save lives.<span><sup>3-5</sup></span> At the same time, craniectomy was performed in another 25% of these patients to prevent postoperative brain edema or intraoperative brain tissue swelling, this proportion can be as high as nearly 50% in patients with severe traumatic brain injury in China.<span><sup>6</sup></span> In most cases, the primary motivation for emergency hematoma removal is to save lives or the noticeable space-occupying effect on computed tomography (CT) images,<span><sup>4</sup></span> however, if the intracranial pressure during emergency surgery allows, whether to remove the bone flap is an essential factor that probably affect the prognosis of patients.</p><p>Recently, in the New England Journal of Medicine, P. J. Hutchinson and colleagues address the comparison of surgical outcomes of craniotomy and decompressive craniectomy (RESCUE-ASDH trial),<span><sup>7</sup></span> it is an investigator-initiated, international, multicenter, pragmatic, randomized trial of patent with a bone flap greater than 11 cm in diameter who accepted the hematoma evacuation. Extended Glasgow Outcome Scale (GOSE) was used to evaluate patients’ outcomes after surgery 12 months later. The mortality and prognosis of the decompressive craniectomy and craniotomy groups were compared at 1, 6 months, and 1 year after operation, and there was no significance in disability and quality-of-life outcomes between two groups. However, the craniotomy group may have to face re-surgery due to difficult-to-control brain edema, while the decompressive craniectomy group may face more trauma-related complications.</p><p>The key conclusions of RESCUE-ASDH trial provide an essential reference for the decision-making of whether to remove the bone flap during the subdural hematoma surgery, that is, if no encephalocele occurs immediately during the operation, reduction of the skull with brain tissue no higher than the plane level of the skull does not increase the risk of poor prognosis. The conclusions are consistent with the recent findings of Thomas A. van Essen et al.,<span><sup>5</sup></span> which pose a significant challenge to previous clinical practice.</p><p>Compared with intracranial
与血肿排空开颅术相比,减压开颅术的颅内并发症发生率更高,且与开颅术相比没有疗效优势,这就为外科医生在手术中提供了更安全的决策选择。
{"title":"Craniectomy versus craniotomy: What can we do for acute subdural hematoma?","authors":"Shuo Zhang,&nbsp;Guoyi Gao,&nbsp;Weiming Liu","doi":"10.1002/agm2.12322","DOIUrl":"10.1002/agm2.12322","url":null,"abstract":"&lt;p&gt;Acute subdural hematoma (ASDH) is one of the common complications after traumatic brain injury (TBI) that warrants surgical evacuation. It often progresses rapidly and has a poor clinical prognosis, due to the mass effect caused by the hematoma and the invasion of the adjacent cerebral cortex and parenchyma. Although with the advancement of surgical techniques, the survival rate after ASDH increased from 59% in 1994–1998 to 73% in 2009–2013,&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; the surgical indications for hematoma evacuation and whether to perform decompression surgery are still controversial which depends on the patient's level of consciousness, pupil status, neuroimaging findings, and intracranial pressure.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; Hematoma evacuation is required in a quarter of patients to save lives.&lt;span&gt;&lt;sup&gt;3-5&lt;/sup&gt;&lt;/span&gt; At the same time, craniectomy was performed in another 25% of these patients to prevent postoperative brain edema or intraoperative brain tissue swelling, this proportion can be as high as nearly 50% in patients with severe traumatic brain injury in China.&lt;span&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt; In most cases, the primary motivation for emergency hematoma removal is to save lives or the noticeable space-occupying effect on computed tomography (CT) images,&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt; however, if the intracranial pressure during emergency surgery allows, whether to remove the bone flap is an essential factor that probably affect the prognosis of patients.&lt;/p&gt;&lt;p&gt;Recently, in the New England Journal of Medicine, P. J. Hutchinson and colleagues address the comparison of surgical outcomes of craniotomy and decompressive craniectomy (RESCUE-ASDH trial),&lt;span&gt;&lt;sup&gt;7&lt;/sup&gt;&lt;/span&gt; it is an investigator-initiated, international, multicenter, pragmatic, randomized trial of patent with a bone flap greater than 11 cm in diameter who accepted the hematoma evacuation. Extended Glasgow Outcome Scale (GOSE) was used to evaluate patients’ outcomes after surgery 12 months later. The mortality and prognosis of the decompressive craniectomy and craniotomy groups were compared at 1, 6 months, and 1 year after operation, and there was no significance in disability and quality-of-life outcomes between two groups. However, the craniotomy group may have to face re-surgery due to difficult-to-control brain edema, while the decompressive craniectomy group may face more trauma-related complications.&lt;/p&gt;&lt;p&gt;The key conclusions of RESCUE-ASDH trial provide an essential reference for the decision-making of whether to remove the bone flap during the subdural hematoma surgery, that is, if no encephalocele occurs immediately during the operation, reduction of the skull with brain tissue no higher than the plane level of the skull does not increase the risk of poor prognosis. The conclusions are consistent with the recent findings of Thomas A. van Essen et al.,&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; which pose a significant challenge to previous clinical practice.&lt;/p&gt;&lt;p&gt;Compared with intracranial","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"276-278"},"PeriodicalIF":2.2,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12322","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141343670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global research and scientific publications on PND between 1969 and 2022: A bibliometric analysis 1969 年至 2022 年间有关 PND 的全球研究和科学出版物:文献计量分析
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-14 DOI: 10.1002/agm2.12310
Ruoxuan Liu, Duan Gao, Ning Yang, Yu Qiao, Zihang Zhang, Mingzhang Zuo
<div> <section> <h3> Objectives</h3> <p>We hope to offer a comprehensive understanding of the advancements and patterns in research on PND. Methods: We performed a thorough search on the Web of Science Core Collection to locate relevant studies published from 1969 to 2022 and utilized four distinct tools, namely VOSviewer (J Data Inf Sci, 2017, 2, 1; J Am Soc Inf Sci, 1973, 24, 265; Amer Doc, 1963, 14, 10 and Scientometrics, 2010, 82, 581), CiteSpace (Scientometrics, 2010, 84, 523), Scimago Graphica, and R-bibliometrix which allowed us to examine various aspects. Results: We included a total of 6787 articles and reviews for analysis which described PND research, the sources, and the subfields; highlighted the significant developments in this field; identified three main directions in PND.Conclusion: This study highlights the rapid growth of research on PND in recent years and provided an overview of previous studies in the field of PND, thereby establishing the overall landscape of PND research and identifying potential avenues for future investigations.</p> </section> <section> <h3> Methods</h3> <p>We performed a thorough search on the Web of Science Core Collection to locate relevant studies published from 1969 to 2022. To perform bibliometric analysis and network visualization, we utilized four distinct tools, namely VOSviewer (J Data Inf Sci, 2017, 2, 1; J Am Soc Inf Sci, 1973, 24, 265; Amer Doc, 1963, 14, 10 and Scientometrics, 2010, 82, 581), CiteSpace (Scientometrics, 2010, 84, 523), Scimago Graphica, and R-bibliometrix. These tools allowed us to examine various aspects, including the yearly publication output, the contribution of different countries or regions, the involvement of active journals, co-citation analysis, publication status, keywords, and terms, as well as scientific categories. We hope to offer a comprehensive understanding of the advancements and patterns in research on PND. The insights gained from this study can assist researchers and clinicians in enhancing the management and implementation of their work in this field.</p> </section> <section> <h3> Results</h3> <p>In this study, we included a total of 6787 articles and reviews for analysis. First, publication trends and contribution by country analysis described PND research. Second, a historical analysis described PND research, the sources, and the subfields. Third, an analysis of keywords highlighted the significant developments in this field. Fourth, an analysis of research themes identified three main directions in PND.</p> </section> <section> <h3> Conclusion</h3> <p>
我们希望全面了解 PND 研究的进展和模式。研究方法我们在 Web of Science Core Collection 上进行了全面搜索,以找到从 1969 年到 2022 年发表的相关研究,并使用了四种不同的工具,即 VOSviewer(J Data Inf Sci,2017,2,1;J Am Soc Inf Sci,1973,24,265;Amer Doc,1963,14,10 和 Scientometrics,2010,82,581)、CiteSpace(Scientometrics,2010,84,523)、Scimago Graphica 和 R-bibliometrix,这使我们能够对各个方面进行研究。结果我们共收录了 6787 篇文章和综述进行分析,这些文章和综述描述了 PND 研究、来源和子领域;强调了该领域的重要发展;确定了 PND 的三个主要方向:本研究强调了近年来 PND 研究的快速发展,并概述了 PND 领域以往的研究,从而确立了 PND 研究的总体格局,并确定了未来研究的潜在方向。为了进行文献计量分析和网络可视化,我们使用了四种不同的工具,即 VOSviewer(J Data Inf Sci,2017,2,1;J Am Soc Inf Sci,1973,24,265;Amer Doc,1963,14,10 和 Scientometrics,2010,82,581)、CiteSpace(Scientometrics,2010,84,523)、Scimago Graphica 和 R-bibliometrix。通过这些工具,我们可以检查各个方面,包括每年的出版物产出、不同国家或地区的贡献、活跃期刊的参与、共引分析、出版状况、关键词和术语以及科学类别。我们希望借此全面了解有关 PND 的研究进展和模式。在本研究中,我们共纳入了 6787 篇文章和综述进行分析。首先,按国家分析了 PND 研究的发表趋势和贡献。其次,历史分析描述了 PND 研究、来源和子领域。第三,关键词分析强调了该领域的重要发展。第四,研究主题分析确定了 PND 的三个主要方向。此外,大部分研究成果来自西方国家和中国。该领域的跨学科性质显而易见,它植根于生物学和医学,并进一步延伸到心理学和社会科学。POCD、以谵妄为主的相关临床管理是有关 PND 的主要研究主题。
{"title":"Global research and scientific publications on PND between 1969 and 2022: A bibliometric analysis","authors":"Ruoxuan Liu,&nbsp;Duan Gao,&nbsp;Ning Yang,&nbsp;Yu Qiao,&nbsp;Zihang Zhang,&nbsp;Mingzhang Zuo","doi":"10.1002/agm2.12310","DOIUrl":"10.1002/agm2.12310","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objectives&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We hope to offer a comprehensive understanding of the advancements and patterns in research on PND. Methods: We performed a thorough search on the Web of Science Core Collection to locate relevant studies published from 1969 to 2022 and utilized four distinct tools, namely VOSviewer (J Data Inf Sci, 2017, 2, 1; J Am Soc Inf Sci, 1973, 24, 265; Amer Doc, 1963, 14, 10 and Scientometrics, 2010, 82, 581), CiteSpace (Scientometrics, 2010, 84, 523), Scimago Graphica, and R-bibliometrix which allowed us to examine various aspects. Results: We included a total of 6787 articles and reviews for analysis which described PND research, the sources, and the subfields; highlighted the significant developments in this field; identified three main directions in PND.Conclusion: This study highlights the rapid growth of research on PND in recent years and provided an overview of previous studies in the field of PND, thereby establishing the overall landscape of PND research and identifying potential avenues for future investigations.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We performed a thorough search on the Web of Science Core Collection to locate relevant studies published from 1969 to 2022. To perform bibliometric analysis and network visualization, we utilized four distinct tools, namely VOSviewer (J Data Inf Sci, 2017, 2, 1; J Am Soc Inf Sci, 1973, 24, 265; Amer Doc, 1963, 14, 10 and Scientometrics, 2010, 82, 581), CiteSpace (Scientometrics, 2010, 84, 523), Scimago Graphica, and R-bibliometrix. These tools allowed us to examine various aspects, including the yearly publication output, the contribution of different countries or regions, the involvement of active journals, co-citation analysis, publication status, keywords, and terms, as well as scientific categories. We hope to offer a comprehensive understanding of the advancements and patterns in research on PND. The insights gained from this study can assist researchers and clinicians in enhancing the management and implementation of their work in this field.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;In this study, we included a total of 6787 articles and reviews for analysis. First, publication trends and contribution by country analysis described PND research. Second, a historical analysis described PND research, the sources, and the subfields. Third, an analysis of keywords highlighted the significant developments in this field. Fourth, an analysis of research themes identified three main directions in PND.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"368-383"},"PeriodicalIF":2.2,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12310","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141339868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploratory bibliometric analysis and text mining to reveal research trends in cardiac aging 探索性文献计量分析和文本挖掘揭示心脏衰老的研究趋势
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-14 DOI: 10.1002/agm2.12329
Takahiro Kamihara, Ken Tanaka, Takuya Omura, Shinji Kaneko, Akihiro Hirashiki, Manabu Kokubo, Atsuya Shimizu

Objectives

We conducted a text mining analysis of 40 years of literature on cardiac aging from PubMed to investigate the current understanding on cardiac aging and its mechanisms. This study aimed to embody what most researchers consider cardiac aging to be.

Methods

We used multiple text mining and machine learning tools to extract important information from a large amount of text.

Results

Analysis revealed that the terms most frequently associated with cardiac aging include “diastolic,” “hypertrophy,” “fibrosis,” “apoptosis,” “mitochondrial,” “oxidative,” and “autophagy.” These terms suggest that cardiac aging is characterized by mitochondrial dysfunction, oxidative stress, and impairment of autophagy, especially mitophagy. We also revealed an increase in the frequency of occurrence of “autophagy” in recent years, suggesting that research on autophagy has made a breakthrough in the field of cardiac aging. Additionally, the frequency of occurrence of “mitophagy” has increased significantly since 2019, suggesting that mitophagy is an important factor in cardiac aging.

Conclusions

Cardiac aging is a complex process that involves mitochondrial dysfunction, oxidative stress, and impairment of autophagy, especially mitophagy. Further research is warranted to elucidate the mechanisms of cardiac aging and develop strategies to mitigate its detrimental effects.

我们对PubMed上40年来有关心脏衰老的文献进行了文本挖掘分析,以了解目前对心脏衰老及其机制的认识。这项研究旨在体现大多数研究人员认为的心脏衰老。我们使用了多种文本挖掘和机器学习工具,从大量文本中提取重要信息。分析表明,与心脏衰老相关的最常见术语包括 "舒张"、"肥大"、"纤维化"、"凋亡"、"线粒体"、"氧化 "和 "自噬"。这些术语表明,心脏衰老的特点是线粒体功能障碍、氧化应激和自噬(尤其是有丝分裂)受损。我们还发现,近年来 "自噬 "出现的频率有所增加,这表明自噬研究在心脏衰老领域取得了突破性进展。此外,自2019年以来,"丝裂噬 "的出现频率明显增加,这表明丝裂噬是心脏衰老的一个重要因素。"心脏衰老是一个复杂的过程,涉及线粒体功能障碍、氧化应激、自噬损伤,尤其是丝裂噬。要阐明心脏衰老的机制并制定减轻其有害影响的策略,还需要进一步的研究。
{"title":"Exploratory bibliometric analysis and text mining to reveal research trends in cardiac aging","authors":"Takahiro Kamihara,&nbsp;Ken Tanaka,&nbsp;Takuya Omura,&nbsp;Shinji Kaneko,&nbsp;Akihiro Hirashiki,&nbsp;Manabu Kokubo,&nbsp;Atsuya Shimizu","doi":"10.1002/agm2.12329","DOIUrl":"10.1002/agm2.12329","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>We conducted a text mining analysis of 40 years of literature on cardiac aging from PubMed to investigate the current understanding on cardiac aging and its mechanisms. This study aimed to embody what most researchers consider cardiac aging to be.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We used multiple text mining and machine learning tools to extract important information from a large amount of text.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Analysis revealed that the terms most frequently associated with cardiac aging include “diastolic,” “hypertrophy,” “fibrosis,” “apoptosis,” “mitochondrial,” “oxidative,” and “autophagy.” These terms suggest that cardiac aging is characterized by mitochondrial dysfunction, oxidative stress, and impairment of autophagy, especially mitophagy. We also revealed an increase in the frequency of occurrence of “autophagy” in recent years, suggesting that research on autophagy has made a breakthrough in the field of cardiac aging. Additionally, the frequency of occurrence of “mitophagy” has increased significantly since 2019, suggesting that mitophagy is an important factor in cardiac aging.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Cardiac aging is a complex process that involves mitochondrial dysfunction, oxidative stress, and impairment of autophagy, especially mitophagy. Further research is warranted to elucidate the mechanisms of cardiac aging and develop strategies to mitigate its detrimental effects.</p>\u0000 </section>\u0000 </div>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"301-311"},"PeriodicalIF":2.2,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12329","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141343278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haste makes waste: Early nutrition prescription for critically ill patients 欲速则不达:危重病人的早期营养处方
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-14 DOI: 10.1002/agm2.12337
Siying Chen, Zhigang Chang
<p>The Nutrirea-3 study was an impactful, multicenter, open-label parallel-group randomized controlled trial (RCT) conducted in 61 intensive care units (ICUs) across France.<span><sup>1</sup></span> The study included patients who were receiving invasive mechanical ventilation and vasopressor therapy for shock, with a median Sequential Organ Failure Assessment (SOFA) score of 10 (8–13) and a median Simplified Acute Physiology Score (SAPS) II of 60 (48–74 points, study group) and 61 (48–74 points, control group), respectively. In total, 3044 patients were randomized into two groups: the low-calorie, low-protein study group (6 kcal/kg/day, 0.2–0.4 g/kg/day) and the standard-calorie, standard-protein control group (25 kcal/kg/day, 1.3 g/kg/day). Enteral nutrition (EN) was administered continuously for 24 h at a constant rate to achieve caloric and protein targets on the first day. The primary outcomes were 90-day all-cause mortality and the number of days until the ICU discharge criteria were met. The secondary outcomes included the rates of secondary infections, gastrointestinal (GI) events, and liver dysfunction. There was no difference in 90-day mortality between the two groups, indicating that high or low calorie and protein intake during the first week did not affect the 90-day mortality rate. The patients in the study group met the ICU discharge criteria 1 day earlier than did those in the control group. Regarding the secondary outcomes, the low-calorie feeding group exhibited lower rates of vomiting, diarrhea, intestinal ischemia, and liver dysfunction, suggesting that increased feeding may be harmful.</p><p>In the past, there was a notion that early and adequate nutrition could improve outcomes, where “adequate” meant achieving sufficient energy intake goals in the early stages of critical illness. However, the publication of the EPaNIC trial in 2011 led to skepticism about this concept.<span><sup>2</sup></span> In this trial, patients who received early supplemental parenteral nutrition (PN) had adverse outcomes that were initially attributed to PN itself. This interpretation led to a significant reduction in the use of PN in clinical practice and recommendations against the use of PN in guidelines.<span><sup>3</sup></span> Since then, accumulating evidence has suggested that providing complete energy targets (i.e., managing nutrition to cover estimated energy expenditure entirely) is detrimental rather than beneficial, regardless of the delivery route. This suggests that clinicians may overestimate patients' energy needs, overfeed patients, or, conversely, encounter biological benefits associated with underfeeding in patients. Some studies have evaluated potential biological mechanisms underlying previous unexpected findings, such as an increased endogenous energy supply independent of the exogenous energy supply and the nutritional suppression of autophagy.<span><sup>4</sup></span></p><p>In the Nutrirea-3 study, patients in the standard f
16 我们提倡早期营养喂养,每天每公斤 10-20 千卡或不超过 500 千卡,以减轻胃肠道不耐受。3 肌肉是内源性氨基酸的主要来源,重症监护病房患者入院时的肌肉质量与重症患者的预后呈正相关。对于多器官功能障碍综合征(MODS)患者而言,入住 ICU 后头 10 天内新陈代谢反应的崩溃可导致肌肉质量减少达每天 1 公斤。EPaNIC 研究的事后分析比较了早期和晚期补充 PN 的情况,发现早期高蛋白摄入与患者的不良预后有关20。另一项回顾性研究 PROTINVENT 也证实了这一点,蛋白质摄入量为 0.8 克/千克/天的患者 6 个月死亡率最高,前 3 天蛋白质摄入量较高(0.8 克/千克/天)的患者死亡率也有所上升。结果显示,对于急性肾损伤和器官功能衰竭评分较高的重症患者,提供较大剂量的蛋白质并不能提高其出院后的存活率,反而可能导致不良后果。18 最近的一项回顾性研究显示,在 ICU 入院期间及早补充蛋白质无不良影响,但 60 天存活率有所提高。23 基于这些有限的信息和primum non nonocere 原则,建议逐渐增加蛋白质目标量。这种方法也适用于热量摄入,在几天内逐渐增加 EN 目标。根据 ESPEN 指南,蛋白质目标应逐渐增加到至少 1.3 克/千克/天。24 NUTRIREA-3 研究深入探讨了接受肠内营养的特定循环休克重症患者的最佳热量和蛋白质摄入量。该研究证实,在危重病人的急性期过早开始全剂量肠内营养对需要大剂量血管加压剂的重症病人不利。肠内营养支持应优先考虑早期启动,但应采取 "少即是多 "的方法。尽管最近的大型多中心 RCT 研究阐明了早期 EN 在脓毒性休克中的作用、时机和剂量,但 ICU 患者的营养需求、耐受性和疾病严重程度各不相同,这阻碍了通用营养治疗方案的制定。因此,对于 ICU 患者来说,"一刀切 "的营养策略并不可行。陈思颖女士和常志刚博士对本稿进行了构思。陈思颖女士和常志刚先生进行了文献检索并撰写了稿件。常志刚博士对手稿进行了严格的修改。
{"title":"Haste makes waste: Early nutrition prescription for critically ill patients","authors":"Siying Chen,&nbsp;Zhigang Chang","doi":"10.1002/agm2.12337","DOIUrl":"10.1002/agm2.12337","url":null,"abstract":"&lt;p&gt;The Nutrirea-3 study was an impactful, multicenter, open-label parallel-group randomized controlled trial (RCT) conducted in 61 intensive care units (ICUs) across France.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; The study included patients who were receiving invasive mechanical ventilation and vasopressor therapy for shock, with a median Sequential Organ Failure Assessment (SOFA) score of 10 (8–13) and a median Simplified Acute Physiology Score (SAPS) II of 60 (48–74 points, study group) and 61 (48–74 points, control group), respectively. In total, 3044 patients were randomized into two groups: the low-calorie, low-protein study group (6 kcal/kg/day, 0.2–0.4 g/kg/day) and the standard-calorie, standard-protein control group (25 kcal/kg/day, 1.3 g/kg/day). Enteral nutrition (EN) was administered continuously for 24 h at a constant rate to achieve caloric and protein targets on the first day. The primary outcomes were 90-day all-cause mortality and the number of days until the ICU discharge criteria were met. The secondary outcomes included the rates of secondary infections, gastrointestinal (GI) events, and liver dysfunction. There was no difference in 90-day mortality between the two groups, indicating that high or low calorie and protein intake during the first week did not affect the 90-day mortality rate. The patients in the study group met the ICU discharge criteria 1 day earlier than did those in the control group. Regarding the secondary outcomes, the low-calorie feeding group exhibited lower rates of vomiting, diarrhea, intestinal ischemia, and liver dysfunction, suggesting that increased feeding may be harmful.&lt;/p&gt;&lt;p&gt;In the past, there was a notion that early and adequate nutrition could improve outcomes, where “adequate” meant achieving sufficient energy intake goals in the early stages of critical illness. However, the publication of the EPaNIC trial in 2011 led to skepticism about this concept.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; In this trial, patients who received early supplemental parenteral nutrition (PN) had adverse outcomes that were initially attributed to PN itself. This interpretation led to a significant reduction in the use of PN in clinical practice and recommendations against the use of PN in guidelines.&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; Since then, accumulating evidence has suggested that providing complete energy targets (i.e., managing nutrition to cover estimated energy expenditure entirely) is detrimental rather than beneficial, regardless of the delivery route. This suggests that clinicians may overestimate patients' energy needs, overfeed patients, or, conversely, encounter biological benefits associated with underfeeding in patients. Some studies have evaluated potential biological mechanisms underlying previous unexpected findings, such as an increased endogenous energy supply independent of the exogenous energy supply and the nutritional suppression of autophagy.&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;In the Nutrirea-3 study, patients in the standard f","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"279-282"},"PeriodicalIF":2.2,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12337","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141343772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between advanced lung cancer inflammation index and in-hospital mortality in ICU patients with community-acquired pneumonia: A retrospective analysis of the MIMIC-IV database 重症监护病房社区获得性肺炎患者的晚期肺癌炎症指数与院内死亡率之间的关系:对MIMIC-IV数据库的回顾性分析
IF 2.2 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2024-06-14 DOI: 10.1002/agm2.12334
Feng Yang, Lianjun Gao, Cuiping Xu, Qimin Wang, Wei Gao

Objective

The objective of the present study was to explore the correlation between the advanced lung cancer inflammation index (ALI) and in-hospital mortality among patients diagnosed with community-acquired pneumonia (CAP).

Methods

Data from the Medical Information Mart for Intensive Care-IV database were adopted to analyze the in-hospital mortality of ICU patients with CAP. Upon admission to the ICU, fundamental data including vital signs, critical illness scores, comorbidities, and laboratory results, were collected. The in-hospital mortality of all CAP patients was documented. Multivariate logistic regression (MLR) models and restricted cubic spline (RCS) analysis together with subgroup analyses were conducted.

Results

This study includes 311 CAP individuals, involving 218 survivors as well as 93 nonsurvivors. The participants had an average age of 63.57 years, and the females accounted for approximately 45.33%. The in-hospital mortality was documented to be 29.90%. MLR analysis found that ALI was identified as an independent predictor for in-hospital mortality among patients with CAP solely in the Q1 group with ALI ≤ 39.38 (HR: 2.227, 95% CI: 1.026–4.831, P = 0.043). RCS analysis showed a nonlinear relationship between the ALI and in-hospital mortality, with a turning point at 81, and on the left side of the inflection point, a negative correlation was observed between ALI and in-hospital mortality (HR: 0.984, 95% CI: 0.975–0.994, P = 0.002). The subgroup with high blood pressure showed significant interaction with the ALI.

Conclusion

The present study demonstrated a nonlinear correlation of the ALI with in-hospital mortality among individuals with CAP. Additional confirmation of these findings requires conducting larger prospective investigations.

本研究旨在探讨晚期肺癌炎症指数(ALI)与确诊为社区获得性肺炎(CAP)患者的院内死亡率之间的相关性。本研究采用重症监护医学信息集市-IV数据库的数据来分析重症监护病房CAP患者的院内死亡率。研究采用了重症监护医学信息市场-IV数据库的数据,分析了重症监护病房 CAP 患者的院内死亡率。记录了所有 CAP 患者的院内死亡率。该研究包括 311 名 CAP 患者,其中 218 人为幸存者,93 人为非幸存者。参与者的平均年龄为 63.57 岁,女性约占 45.33%。院内死亡率为 29.90%。MLR分析发现,在ALI≤39.38的Q1组中,ALI是CAP患者院内死亡率的独立预测因素(HR:2.227,95% CI:1.026-4.831,P = 0.043)。RCS分析显示,ALI与院内死亡率之间存在非线性关系,在81时出现拐点,在拐点左侧,ALI与院内死亡率之间呈负相关(HR:0.984,95% CI:0.975-0.994,P = 0.002)。本研究表明,ALI 与 CAP 患者的院内死亡率存在非线性相关性。要进一步证实这些发现,需要进行更大规模的前瞻性研究。
{"title":"Association between advanced lung cancer inflammation index and in-hospital mortality in ICU patients with community-acquired pneumonia: A retrospective analysis of the MIMIC-IV database","authors":"Feng Yang,&nbsp;Lianjun Gao,&nbsp;Cuiping Xu,&nbsp;Qimin Wang,&nbsp;Wei Gao","doi":"10.1002/agm2.12334","DOIUrl":"10.1002/agm2.12334","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>The objective of the present study was to explore the correlation between the advanced lung cancer inflammation index (ALI) and in-hospital mortality among patients diagnosed with community-acquired pneumonia (CAP).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data from the Medical Information Mart for Intensive Care-IV database were adopted to analyze the in-hospital mortality of ICU patients with CAP. Upon admission to the ICU, fundamental data including vital signs, critical illness scores, comorbidities, and laboratory results, were collected. The in-hospital mortality of all CAP patients was documented. Multivariate logistic regression (MLR) models and restricted cubic spline (RCS) analysis together with subgroup analyses were conducted.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>This study includes 311 CAP individuals, involving 218 survivors as well as 93 nonsurvivors. The participants had an average age of 63.57 years, and the females accounted for approximately 45.33%. The in-hospital mortality was documented to be 29.90%. MLR analysis found that ALI was identified as an independent predictor for in-hospital mortality among patients with CAP solely in the Q1 group with ALI ≤ 39.38 (HR: 2.227, 95% CI: 1.026–4.831, <i>P</i> = 0.043). RCS analysis showed a nonlinear relationship between the ALI and in-hospital mortality, with a turning point at 81, and on the left side of the inflection point, a negative correlation was observed between ALI and in-hospital mortality (HR: 0.984, 95% CI: 0.975–0.994, <i>P</i> = 0.002). The subgroup with high blood pressure showed significant interaction with the ALI.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The present study demonstrated a nonlinear correlation of the ALI with in-hospital mortality among individuals with CAP. Additional confirmation of these findings requires conducting larger prospective investigations.</p>\u0000 </section>\u0000 </div>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 3","pages":"350-359"},"PeriodicalIF":2.2,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12334","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141338939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Aging Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1